2737-7946

Acta Materia Medica

Compuscript, Ltd.

Health Score

0 Good

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Attach ORCID iDs across 151 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact151 DOIs
2

Add abstracts to 8 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact8 DOIs
3

Deposit reference lists for 6 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact6 DOIs

DOIs for this ISSN

Showing the top 5 of 161 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Drug discovery is an eternal challenge for the biomedical sc… (10.15212/amm-2022-1001)
Abstract ORCID
91.63 67
2 PROTAC degraders with ligands recruiting MDM2 E3 ubiquitin l… (10.15212/amm-2022-0010)
ORCID
38.29 33
3 Role of natural products in tumor therapy from basic researc… (10.15212/amm-2023-0050)
ORCID
37.96 32
4 Multi-component Chinese medicine formulas for drug discovery… (10.15212/amm-2022-0049)
ORCID
37.63 31
5 PROTAC technology for the treatment of Alzheimer’s disease:… (10.15212/amm-2021-0001)
ORCID
36.18 27
6 Recent advances in nano-targeting drug delivery systems for… (10.15212/amm-2022-0039)
ORCID
36.18 27
7 Molecular networking as a natural products discovery strateg… (10.15212/amm-2023-0007)
ORCID
34.95 24
8 Brusatol modulates diverse cancer hallmarks and signaling pa… (10.15212/amm-2022-0014)
ORCID
34.51 23
9 Smart stimuli-responsive carrier-free nanoassembly of SN38 p… (10.15212/amm-2023-0003)
ORCID
32.53 19
10 Advances in therapeutic nanodrug delivery systems for infect… (10.15212/amm-2022-0019)
ORCID
31.97 18
11 Small-molecule fluorescence-based probes for aging diagnosis (10.15212/amm-2021-0004)
ORCID
31.38 17
12 Identification of a cytisine-based EED-EZH2 protein-protein… (10.15212/amm-2022-0006)
ORCID
31.38 17
13 Functions and therapeutic potentials of exosomes in osteosar… (10.15212/amm-2022-0024)
ORCID
31.38 17
14 Ligands for oral delivery of peptides across the blood-brain… (10.15212/amm-2021-0007)
ORCID
30.76 16
15 Recent progress in cancer therapy based on the combination o… (10.15212/amm-2022-0025)
ORCID
30.10 15
16 Cancer treatment: from traditional Chinese herbal medicine t… (10.15212/amm-2022-0035)
ORCID
30.10 15
17 Advances in nanoscale carrier-based approaches to reduce tox… (10.15212/amm-2023-0038)
ORCID
30.10 15
18 Regulation of neuronal autophagy and cell survival by MCL1 i… (10.15212/amm-2021-0002)
ORCID
29.40 14
19 New lathyrane diterpenoid hybrids have anti-inflammatory act… (10.15212/amm-2022-0008)
ORCID
29.40 14
20 Animal models of Alzheimer’s disease: preclinical insights a… (10.15212/amm-2023-0001)
ORCID
29.40 14
21 Aging and cancer hallmarks as therapeutic targets (10.15212/amm-2023-0018)
ORCID
29.40 14
22 Senescence-associated lncRNAs indicate distinct molecular su… (10.15212/amm-2023-0025)
ORCID
29.40 14
23 Application of PROTACs in target identification and validati… (10.15212/amm-2024-0010)
ORCID
29.40 14
24 Exploring food and medicine homology: potential implications… (10.15212/amm-2025-0003)
ORCID
29.40 14
25 Computational strategies for PROTAC drug discovery (10.15212/amm-2022-0041)
ORCID
28.65 13
26 New generation estrogen receptor-targeted agents in breast c… (10.15212/amm-2024-0006)
ORCID
28.65 13
27 Oral delivery of glutathione: antioxidant function, barriers… (10.15212/amm-2022-0005)
ORCID
27.85 12
28 Silybin has therapeutic efficacy against non-small cell lung… (10.15212/amm-2022-0011)
ORCID
27.85 12
29 Structure prediction of the entire proteome of monkeypox var… (10.15212/amm-2022-0017)
ORCID
27.85 12
30 The direct STAT3 inhibitor 6-ethoxydihydrosanguinarine exhib… (10.15212/amm-2022-0027)
ORCID
27.85 12
31 STING agonist delivery by lipid calcium phosphate nanopartic… (10.15212/amm-2023-0011)
ORCID
27.85 12
32 Structurally diverse polydopamine-based nanomedicines for ca… (10.15212/amm-2022-0023)
ORCID
26.98 11
33 Discovery of a pyridophenoselenazinium-based photosensitizer… (10.15212/amm-2023-0002)
ORCID
26.98 11
34 Novel emerging nano-assisted anti-cancer strategies based on… (10.15212/amm-2023-0023)
ORCID
26.98 11
35 Advances in therapeutic agents targeting quiescent cancer ce… (10.15212/amm-2021-0005)
ORCID
26.03 10
36 Mass spectrometry imaging advances and application in pharma… (10.15212/amm-2022-0046)
ORCID
26.03 10
37 Exploitation of platelets for antitumor drug delivery and mo… (10.15212/amm-2023-0005)
ORCID
26.03 10
38 Sesquiterpenoids from the sunflower family as potential anti… (10.15212/amm-2023-0026)
ORCID
26.03 10
39 Prognosis and treatment of complications associated with COV… (10.15212/amm-2022-0002)
ORCID
25.00 9
40 MDM2-BCL-XL PROTACs enable degradation of BCL-XL and stabili… (10.15212/amm-2022-0022)
ORCID
25.00 9
41 ZnPc photosensitizer-loaded peony-shaped FeSe2 remotely cont… (10.15212/amm-2023-0012)
ORCID
25.00 9
42 Recent advances in the molecular design and applications of… (10.15212/amm-2023-0019)
ORCID
25.00 9
43 Structural diversity and biological activities of caged Garc… (10.15212/amm-2022-0001)
ORCID
23.86 8
44 Emerging role of HJURP as a therapeutic target in cancers (10.15212/amm-2023-0008)
ORCID
23.86 8
45 Endocrine toxicity of immune checkpoint inhibitors: a networ… (10.15212/amm-2023-0037)
ORCID
23.86 8
46 Protective effects of ginsenoside CK against oxidative stres… (10.15212/amm-2022-0009)
ORCID
22.58 7
47 The ‘New (Nu)-clear’ evidence of the tumor-driving role of P… (10.15212/amm-2022-0013)
ORCID
22.58 7
48 Cytotoxic compounds from marine actinomycetes: sources, stru… (10.15212/amm-2022-0028)
ORCID
22.58 7
49 In vitro characterization and cellular uptake profiles of TA… (10.15212/amm-2022-0030)
ORCID
22.58 7
50 Corrigendum to: Silybin has therapeutic efficacy against non… (10.15212/amm-2023-1001)
Abstract References ORCID
22.58 1